NCT06171789
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06171789
Title PRO1107 in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ProfoundBio US Co.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Florida Cancer Specialists Sarasota Florida 34236 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
START Mountain Cancer Center Salt Lake City Utah 78229 United States Details
Institution of Hunan Cancer Hospital Changsha Hunan 410013 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field